MSF welcomes Ministry of Commerce clarification on Compulsory Licensing
Warns US pressure on India will continue
The Ministry of Commerce recently clarified that media reports claiming that the…
Author
Apeiron Biologics and Columbia University sign exclusive license agreement
To develop and commercialise active cellular immunotherapies under licensed patents, which cover inhibition of Cbl-b in T cells…
EY Entrepreneur of The Year Awards announced
Vinita and Nilesh Gupta of Lupin and Samir Mehta of Torrent Pharma receive the award
Vinita Gupta, Chief Executive Officer and…
CphI India Pre-Connect Congress held in Mumbai
Experts discuss the current trends in pharma industry at the event
The CphI India Pre-Connect Congress recently held in Mumbai,…
Cipla ready to launch low-dose Efavirenz 400 mg
Studies found that the reduced dose of 400 mg Efavirenz was non-inferior to the standard dose of 600 mg Efavirenz dose
Clinical trials for new diabetes drugs urgently needed In India: ISCR
On the occasion of World Diabetes Day (November 14), the Indian Society for Clinical Research (ISCR), an association of clinical…
Experts address impact of M&A in pharma and promoting API manufacturing in India
M&A report recommendations focused on pricing, production and availability, R&D and social consequences
In order to…
Glenmark’s bi-apecific antibody – GBR 1302 to enter Phase I trials
Glenmark expects to obtain approval for the initiation of clinical studies with GBR1302 during this financial year
Glenmark…
Study: Tresiba U200 delivers significantly lower rates of confirmed hypoglycaemia vs insulin…
More concentrated formulation means fewer injections, and consequently better patient compliance
New data presented at the 51st…
Industry titans Biocon, PBOA, PCI Clinical Services and Pharmatech Associates join CPhI annual…
Dr Fiona Withey, Managing Director UK PCI Clinical Services, first ever female executive to join the expert panel
CPhI Worldwide,…